Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Intern Med. 2010 Oct 19;153(8):532-5. doi: 10.7326/0003-4819-153-8-201010190-00010.

What's in placebos: who knows? Analysis of randomized, controlled trials.

Author information

  • 1University of California, San Diego, School of Medicine, San Diego, California, USA. bgolomb@ucsd.edu

Abstract

BACKGROUND:

No regulations govern placebo composition. The composition of placebos can influence trial outcomes and merits reporting.

PURPOSE:

To assess how often investigators specify the composition of placebos in randomized, placebo-controlled trials.

DATA SOURCES:

4 English-language general and internal medicine journals with high impact factors.

STUDY SELECTION:

3 reviewers screened titles and abstracts of the journals to identify randomized, placebo-controlled trials published from January 2008 to December 2009.

DATA EXTRACTION:

Reviewers independently abstracted data from the introduction and methods sections of identified articles, recording treatment type (pill, injection, or other) and whether placebo composition was stated. Discrepancies were resolved by consensus.

DATA SYNTHESIS:

Most studies did not disclose the composition of the study placebo. Disclosure was less common for pills than for injections and other treatments (8.2% vs. 26.7%; P = 0.002).

LIMITATION:

Journals with high impact factors may not be representative.

CONCLUSION:

Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.

PMID:
20956710
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk